124 related articles for article (PubMed ID: 911169)
1. Failure to induce tolerance to mechlorethamine hydrochloride.
Leshaw S; Simon RS; Bear RL
Arch Dermatol; 1977 Oct; 113(10):1406-8. PubMed ID: 911169
[TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G
Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
[TBL] [Abstract][Full Text] [Related]
3. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
Constantine VS; Fuks ZY; Farber EM
Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
[TBL] [Abstract][Full Text] [Related]
4. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
[TBL] [Abstract][Full Text] [Related]
5. The treatment of mycosis fungoides with ointment-based mechlorethamine.
Price NM; Deneau DG; Hoppe RT
Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
[TBL] [Abstract][Full Text] [Related]
6. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
Shelley WB
Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
[TBL] [Abstract][Full Text] [Related]
7. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
Ramsay DL; Parnes RE; Dubin N
Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
[TBL] [Abstract][Full Text] [Related]
8. Intravenous desensitization to mechlorethamine in patients with psoriasis.
Pariser DM; Childers RC; Kechijian P; Halprin KM; Taylor JR
Arch Dermatol; 1976 Aug; 112(8):1113-4. PubMed ID: 952529
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
10. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
Van Scott EJ; Kalmanson JD
Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
[No Abstract] [Full Text] [Related]
11. Mechlorethamine in psoriasis. Further attempts to induce immunological tolerance.
Breza TS; Kechijian P; Taylor JR
Arch Dermatol; 1975 Nov; 111(11):1438-9. PubMed ID: 1200651
[TBL] [Abstract][Full Text] [Related]
12. Topical mechlorethamine therapy for mycosis fungoides.
Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
[TBL] [Abstract][Full Text] [Related]
13. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
Price NM
Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
[TBL] [Abstract][Full Text] [Related]
14. Topical nitrogen mustard in mycosis fungoides.
Zachariae H
Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
[TBL] [Abstract][Full Text] [Related]
15. [Mycosis fungoides].
Volden G; Eeg Larsen T
Tidsskr Nor Laegeforen; 1977 Nov; 97(32):1671-5. PubMed ID: 594965
[No Abstract] [Full Text] [Related]
16. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
Zachariae H; Thestrup-Pedersen K; Søgaard H
Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
[TBL] [Abstract][Full Text] [Related]
17. Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
Vonderheid EC; Dellatorre DL; Van Scott EJ
Arch Dermatol; 1981 Sep; 117(9):586-9. PubMed ID: 6457569
[TBL] [Abstract][Full Text] [Related]
18. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
Volden G; Molin L; Thomsen K
Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
[No Abstract] [Full Text] [Related]
19. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
Vonderheid EC; Ekbote SK; Kerrigan K; Kalmanson JD; Van Scott EJ; Rook AH; Abrams JT
J Invest Dermatol; 1998 Jun; 110(6):946-50. PubMed ID: 9620303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]